JC Virchow

2.0k total citations
33 papers, 1.4k citations indexed

About

JC Virchow is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, JC Virchow has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 16 papers in Pulmonary and Respiratory Medicine and 9 papers in Immunology and Allergy. Recurrent topics in JC Virchow's work include Asthma and respiratory diseases (23 papers), Allergic Rhinitis and Sensitization (9 papers) and Respiratory and Cough-Related Research (7 papers). JC Virchow is often cited by papers focused on Asthma and respiratory diseases (23 papers), Allergic Rhinitis and Sensitization (9 papers) and Respiratory and Cough-Related Research (7 papers). JC Virchow collaborates with scholars based in Germany, United Kingdom and France. JC Virchow's co-authors include Claus Kroegel, Joaquim Mullol, Giorgio Walter Canonica, H Matthys, Jean Bousquet, Werner Luttmann, G. K. Scadding, Peter Julius, Susanne S. Pedersen and Peter J. Barnes and has published in prestigious journals such as European Respiratory Journal, Thorax and Allergy.

In The Last Decade

JC Virchow

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JC Virchow Germany 16 1.0k 586 582 256 162 33 1.4k
U. Alkner Sweden 16 619 0.6× 483 0.8× 427 0.7× 121 0.5× 73 0.5× 36 1.1k
Jerzy Jarząb Poland 20 585 0.6× 209 0.4× 492 0.8× 113 0.4× 301 1.9× 70 967
Alessandra Sandrini Australia 16 529 0.5× 587 1.0× 258 0.4× 66 0.3× 93 0.6× 21 1.1k
Tara F. Carr United States 19 776 0.8× 563 1.0× 289 0.5× 245 1.0× 67 0.4× 48 1.3k
Grzegorz Cieslewicz United States 13 812 0.8× 358 0.6× 271 0.5× 493 1.9× 48 0.3× 20 1.2k
JOHN V. FAHY United States 13 1.1k 1.1× 964 1.6× 253 0.4× 352 1.4× 37 0.2× 14 1.7k
Young Mok Lee South Korea 20 500 0.5× 364 0.6× 172 0.3× 343 1.3× 73 0.5× 43 1.1k
Eliot H. Dunsky United States 17 399 0.4× 199 0.3× 370 0.6× 229 0.9× 121 0.7× 26 832
Darío Antolín‐Amérigo Spain 15 268 0.3× 109 0.2× 493 0.8× 99 0.4× 182 1.1× 66 784
Vijay Mistry United Kingdom 17 1.1k 1.1× 1.1k 1.8× 125 0.2× 450 1.8× 37 0.2× 44 1.7k

Countries citing papers authored by JC Virchow

Since Specialization
Citations

This map shows the geographic impact of JC Virchow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JC Virchow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JC Virchow more than expected).

Fields of papers citing papers by JC Virchow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JC Virchow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JC Virchow. The network helps show where JC Virchow may publish in the future.

Co-authorship network of co-authors of JC Virchow

This figure shows the co-authorship network connecting the top 25 collaborators of JC Virchow. A scholar is included among the top collaborators of JC Virchow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JC Virchow. JC Virchow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lommatzsch, Marek, Roland Buhl, Karl‐Christian Bergmann, et al.. (2025). Eosinophils in asthma phenotypes: perpetrators or guilty by association?. The Lancet Respiratory Medicine. 13(10). 943–950. 2 indexed citations
2.
Brusselle, Guy, JC Virchow, Liam G. Heaney, et al.. (2023). M21 On-treatment clinical remission with tezepelumab in patients with severe, uncontrolled asthma in the phase 3 DESTINATION study. A272–A273. 3 indexed citations
3.
Bachert, Claus, et al.. (2015). MP29-02*provides effective AR symptom control in real life in all patient types regardless of predominant nasal symptom or presence of ocular symptoms: results from Germany. Kölner Universitäts PublikationsServer (Universität zu Köln). 1 indexed citations
4.
Virchow, JC, et al.. (2015). MP29-02* provides effective AR symptom control in real life in previous or potential treatment failure patients : results from Germany. Allergy. 70. 503–503. 1 indexed citations
5.
6.
Canonica, Giorgio Walter, Jean Bousquet, Joaquim Mullol, et al.. (2013). A new allergic rhinitis therapy (MP29-02) is more effective than current first line monotherapies in providing allergic rhinitis patients relief from their nasal and ocular symptoms (rTNSS, rT5SS, rT7SS). Ghent University Academic Bibliography (Ghent University). 3 indexed citations
7.
Carr, Warner, Paul H. Ratner, Ullrich Munzel, et al.. (2012). Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis. Allergy and Asthma Proceedings. 33(6). 450–458. 20 indexed citations
8.
9.
Bousquet, Jean, Christopher Winchester, Alberto Papi, et al.. (2011). Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist Combination Therapy for Asthma: Attitudes of Specialists in Europe. International Archives of Allergy and Immunology. 157(3). 303–310. 18 indexed citations
10.
Haughney, John, David Price, Neil Barnes, et al.. (2011). Iconography : Choosing inhaler devices for people with asthma: Current knowledge and outstanding research needs. 1 indexed citations
11.
Virchow, JC, G K Crompton, Roberto Dal Negro, et al.. (2007). Importance of inhaler devices in the management of airway disease. Respiratory Medicine. 102(1). 10–19. 235 indexed citations
12.
Canonica, Giorgio Walter, Jean Bousquet, Joaquim Mullol, G. K. Scadding, & JC Virchow. (2007). A survey of the burden of allergic rhinitis in Europe. Allergy. 62(s85). 17–25. 358 indexed citations
13.
14.
Kallinich, Tilmann, Stephanie Schmidt, Eckard Hamelmann, et al.. (2005). Chemokine‐receptor expression on T cells in lung compartments of challenged asthmatic patients. Clinical & Experimental Allergy. 35(1). 26–33. 41 indexed citations
15.
16.
Julius, Peter, et al.. (1999). CD69 surface expression on human lung eosinophils after segmental allergen provocation. European Respiratory Journal. 13(6). 1253–1259. 32 indexed citations
17.
Virchow, JC, Peter Julius, H Matthys, Claus Kroegel, & Werner Luttmann. (1998). CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma. European Respiratory Journal. 11(2). 317–323. 57 indexed citations
18.
Kroegel, Claus, Peter Julius, H Matthys, JC Virchow, & Werner Luttmann. (1996). Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. European Respiratory Journal. 9(5). 899–904. 122 indexed citations
19.
Kroegel, Claus, et al.. (1994). Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I). European Respiratory Journal. 7(3). 519–543. 102 indexed citations
20.
Kroegel, Claus, et al.. (1994). Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part II). European Respiratory Journal. 7(4). 743–760. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U. Alkner Breakdown of academic impact, for papers by Jerzy Jarząb Breakdown of academic impact, for papers by Alessandra Sandrini Breakdown of academic impact, for papers by Tara F. Carr Breakdown of academic impact, for papers by Grzegorz Cieslewicz Breakdown of academic impact, for papers by JOHN V. FAHY Breakdown of academic impact, for papers by Young Mok Lee Breakdown of academic impact, for papers by Eliot H. Dunsky Breakdown of academic impact, for papers by Darío Antolín‐Amérigo Breakdown of academic impact, for papers by Vijay Mistry
Rankless by CCL
2026